ART into Science: Regulation of Fertility Techniques

Abstract
Unlike other areas of medical innovation, no comprehensive regulatory framework exists in the United States for alternative reproductive technologies. Because of problems such as experimentation without appropriate review, use of embryos without consent, conflicts regarding control over stored gametes and embryos, and failure to routinely screen donors for disease, this article recommends a federal oversight mechanism to assure that basic human subjects protections be applied in the infertility context.